MARDUEL ALIX 4
4 · CORCEPT THERAPEUTICS INC · Filed Mar 26, 2008
Insider Transaction Report
Form 4
MARDUEL ALIX
Director10% Owner
Transactions
- Purchase
Common Stock
[F1][F2]2008-03-25$2.77/sh+1,045,921$2,897,201→ 5,043,299 total(indirect: By Fund) - Purchase
Common Stock
[F2][F3]2008-03-25$2.77/sh+13,214$36,603→ 166,491 total(indirect: By Fund) - Purchase
Warrant
[F1][F2]2008-03-25$0.13/sh+522,960$65,370→ 522,960 total(indirect: By Fund)Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (522,960 underlying) - Purchase
Warrant
[F2][F3]2008-03-25$0.13/sh+6,607$826→ 6,607 total(indirect: By Fund)Exercise: $2.77From: 2008-03-25Exp: 2015-03-25→ Common (6,607 underlying)
Footnotes (3)
- [F1]These securities are held by Alta BioPharma Partners II, L.P. ("ABPII").
- [F2]The Reporting Person is a managing director of Alta BioPharma Management II, LLC ("ABMII"), which is the general partner of ABPII , and a manager of Alta Embarcadero Partners II, LLC ("AEBPII" and, along with ABPII, the "Funds"). The Reporting Person may be deemed to share voting and investment power over the shares held by the Funds. The Reporting Person disclaims beneficial ownership of all such shares held by the Funds, except to the extent of her pecuniary interests therein.
- [F3]These securities are held by AEBPII.
Signature
Alix Marduel|2008-03-26